Gannon C: The prescription of steroids in the terminal phase. Palliat Med. 2001; 15: 522.
6.
Needham PR, Daley AG, Lennard RF: Steroids in advanced cancer: Survey of current practice. BMJ. 1992; 305: 999.
7.
Rousseau PC: The palliative use of high-dose corticosteroids in three terminally ill patients with pain. Am J Hosp Palliat Care. 2001; 18: 343-346.
8.
Laval G, Girardier J, Lassauniere JM, et al.: The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: Do they remove obstruction?Palliat Med. 2000; 14: 3-10.
9.
Feuer DJ, Broadley KE: Systematic review and meta-analysis of corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancers. Ann Oncol. 1999; 10: 1035-1041.
10.
Hempen C, Weiss E, Hess CF: Dexamethasone treatment in patients with brain metastases and primary brain tumors: Do the benefits outweigh the side-effects?Support Care Cancer. 2002; 10: 322-328.
11.
Philip J, Lickiss N, Grant PT, et al.: Corticosteroids in the management of bowel obstruction on a gynecological oncology unit. Gynecol Oncol. 1999; 74: 68-73.
12.
Moertel CG, Schutt AJ, Reitemeier RJ, et al.: Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer. 1974; 33: 1607-1609.
13.
Sweeney C, Bruera E: New roles for old drugs: Corticosteroids. Prog Palliat Care. 2001; 9: 53-54.
14.
Hardy JR, Rees E, Ling J, et al.: A prospective survey of the use of dexamethasone on a palliative care unit. Palliat Med. 2001; 15: 3-8.
15.
Kountz DS, Clark C: Safely withdrawing patients from chronic corticosteroid therapy. Am Fam Phys. 1997; 55: 521-530.